|
|
||||||||
Neurology and Medical Research Service, Veterans Administration Medical Center, Department of Neurology, University of Florida College of Medicine, Gainesville, FL (Drs. Wilder, Karas, and Hammond); Neurology and Medical Research Service, Veterans Administration Medical Center and University of Miami School of Medicine, Miami, FL (Dr. Ramsay); and Milwaukee Pediatric Neurology, Milwaukee, WI (Dr. Murphy and Ms. Marquardt).
Sixty-one newly diagnosed epileptic patients with generalized tonic-clonic, clonic, or tonic seizures were randomly allocated to treatment with valproate (VPA) and phenytoin (PHT). After 6 months, both drugs had been effective in preventing recurrence of seizures. Seventy-three percent of patients receiving VPA and 47% of patients receiving PHT had no recurrences. Side effects of either drug were mild. Laboratory abnormalities were similar for both drugs. Except for one PHT patient with toxic hepatitis, therapy was not discontinued.
Address correspondence and reprint requests to Dr. Wilder, Chief, Neurology Service (127). Veterans Administration Medical Center, Gainesville, FL 32602.
This work was supported by the Medical Research Service of the Veterans Administration, the Epilepsy Research Foundation of Florida, Inc., and the Southern Foundation for Brain Research.
Accepted for publication March 2, 1983
This article has been cited by other articles:
![]() |
A Nicolson, R E Appleton, D W Chadwick, and D F Smith The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 75 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Wheless Use of Topiramate in Childhood Generalized Seizure Disorders J Child Neurol, December 1, 2000; 15(1_suppl): S7 - S13. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |